This report is the third in a series of reports commissioned by the Office of the Assistant Secretary for Planning and Evaluation (ASPE) from the RAND Corporation addressing state all payer claims databases (APCDs). APCDs include medical, pharmacy, and dental claims, as well as enrollment and provider files collected from private and public payers by states, usually as part of a State mandate.
Employer-Sponsored & Private Health Insurance
Reports
Displaying 1 - 10 of 27. 10 per page. Page 1.
Advanced SearchReport
Understanding Coverage Considerations for COVID-19 Vaccines and Treatments
Understanding Coverage Considerations for COVID-19 Vaccines and Treatments (Updated May 2023)
ASPE Issue Brief
Marketplace Coverage and Economic Benefits: Key Issues and Evidence
This report highlights the impacts of the Affordable Care Act's Marketplace subsidies on coverage rates among self-employed adults and small business owners, based on tax data from the Department of Treasury and national survey data.
ASPE Issue Brief
Evidence on Surprise Billing: Protecting Consumers with the No Surprises Act
On January 1, 2022, the surprise billing provisions of the Consolidated Appropriations Act, 2021 - commonly referred to as the No Surprises Act - go into effect. Surprise billing occurs when a privately insured individual receives an unexpected bill either in an emergency situation or when a service in an in-network facility is provided by an out-of-network provider.
ASPE Issue Brief
Air Ambulance Use and Surprise Billing
Air ambulances are used to transport patients in critical situations from the scene of an injury or accident to hospitals, or between hospitals.
ASPE Issue Brief
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief Mir M. Ali, Kristina West, and Emma Nye U.S. Department of Health and Human Services
Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report
ABSTRACT
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report
This project assessed changes in Opioid Use Disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market at two timepoints, 2006-2007 and 2014-2015, that mark the periods before and after implementation of the Mental Health Parity and Addiction Equity Act (MHPAEA), the Affordable Care Act, the introduction and expanded use of new opioid treatme
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Out-of-Pocket Costs
This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014.